Choi Eunho, Lee Seunghee, Yeom Seon-Yong, Kim Geun Hyang, Lee Jae Woon, Kim Seung-Whan
Division Diabetes, Endocrinology & Metabolism, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Mol Endocrinol. 2005 Jul;19(7):1711-9. doi: 10.1210/me.2005-0066. Epub 2005 Mar 10.
Activating signal cointegrator-2 (ASC-2) is a recently isolated transcriptional coactivator protein for a variety of different transcription factors, including many members of the nuclear receptor superfamily. In this report, we demonstrate that ASC-2 also serves as a coactivator of the xenobiotic nuclear receptor constitutive androstane receptor (CAR). First, transcriptional activation by CAR was enhanced by cotransfected ASC-2 in CV-1 and HeLa cells. In contrast, CAR transactivation was significantly impaired in HepG2 cells stably expressing specific small interfering RNA directed against ASC-2. Consistent with these results, chromatin immunoprecipitation experiments revealed that ASC-2 is recruited to the known CAR target genes in a ligand-dependent manner. Secondly, CAR specifically interacted with the first LXXLL motif of ASC-2, and these interactions were stimulated by CAR agonist 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene and repressed by CAR inverse agonist androstanol, suggesting that this motif may mediate the interactions of ASC-2 and CAR in vivo. In support of this idea, DN1, a fragment of ASC-2 encompassing the first LXXLL motif, suppressed CAR transactivation, and coexpressed ASC-2 but not other LXXLL-type coactivators such as thyroid hormone receptor-associated protein 220 reversed this repression. Finally, CAR was recently found to play a pivotal role in effecting the severe acetaminophen-induced liver damage. Interestingly, transgenic mice expressing DN1 were resistant to the acetaminophen-induced hepatotoxicity and expression of a series of the known CAR target genes was specifically repressed in these transgenic mice. Taken together, these results strongly suggest that ASC-2 is a bona fide coactivator of the xenobiotic nuclear receptor CAR and mediate the specific xenobiotic response by CAR in vivo.
激活信号共整合因子2(ASC-2)是一种最近分离出的转录共激活蛋白,可作用于多种不同的转录因子,包括核受体超家族的许多成员。在本报告中,我们证明ASC-2也是外源性核受体组成型雄甾烷受体(CAR)的共激活因子。首先,在CV-1和HeLa细胞中,共转染的ASC-2增强了CAR的转录激活作用。相反,在稳定表达针对ASC-2的特异性小干扰RNA的HepG2细胞中,CAR的反式激活作用明显受损。与这些结果一致,染色质免疫沉淀实验表明,ASC-2以配体依赖的方式被招募到已知的CAR靶基因上。其次,CAR与ASC-2的第一个LXXLL基序特异性相互作用,这些相互作用受到CAR激动剂1,4-双[2-(3,5-二氯吡啶氧基)]苯的刺激,并被CAR反向激动剂雄甾醇抑制,这表明该基序可能在体内介导ASC-2与CAR的相互作用。支持这一观点的是,包含第一个LXXLL基序的ASC-2片段DN1抑制了CAR的反式激活作用,而共表达的ASC-2而非其他LXXLL型共激活因子(如甲状腺激素受体相关蛋白220)可逆转这种抑制作用。最后,最近发现CAR在对乙酰氨基酚引起的严重肝损伤中起关键作用。有趣的是,表达DN1的转基因小鼠对乙酰氨基酚诱导的肝毒性具有抗性,并且在这些转基因小鼠中一系列已知的CAR靶基因的表达被特异性抑制。综上所述,这些结果强烈表明ASC-2是外源性核受体CAR的真正共激活因子,并在体内介导CAR的特异性外源性反应。